Modifications to Botulinum toxin A delivery in the management of detrusor overactivity recalcitrant to initial injections: a review

World Journal of Urology
A DohertyJ Gani

Abstract

One quarter of patients will not respond to initial intra-detrusor Botulinum toxin A (BTX) injections for detrusor overactivity. Alternative treatment options include long-term catheterization, sacral neuromodulation, urinary diversion or bladder augmentation. Some of these procedures are invasive. This review explores modifications to BTX delivery that can improve outcome. A search of Medline, Embase and Cochrane Library to December 2017 was performed according to Preferred Reporting Items for Systematic Review and Metaanalysis (PRISMA) guidelines. Search criteria included, dose escalation, increasing injection site number, trigone injection, switching preparation and alternative methods of BTX delivery. Several modifications to BTX delivery may improve response. There is moderate evidence that increasing the dose from 100 U to 200 U results in statistically better symptom control. Trigone-including injections were associated with significantly improved patient-reported symptom scores, as well as superior results in urodynamic outcomes without risking urinary retention and vesico-ureteric reflux. Switching from onabotulinum (OTA) or abobotulinum (ATA) or vice versa may also improve response in over 50% of patients as shown in ...Continue Reading

References

Sep 1, 1995·Neurology·J Jankovic, K Schwartz
Oct 17, 1998·World Journal of Urology·C R Chapple, N P Bryan
May 15, 2002·Urology·Karl-Erik Andersson
Jul 22, 2004·Current Medical Research and Opinion·Markus Naumann, Joseph Jankovic
Dec 14, 2011·The Cochrane Database of Systematic Reviews·James B DuthieDon Wilson
Feb 8, 2013·Neurourology and Urodynamics·Eric RovnerCornelia Haag-Molkenteller
May 7, 2013·The Journal of Urology·Bruce J SchlomerLaurence Baskin
Jul 10, 2013·Actas urologicas españolas·M G LucasR S Pickard
Jun 22, 2015·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M LacoutG Amarenco
Sep 1, 2015·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·B PeyronnetUNKNOWN Membres du GENULF (Groupe d’étude de neuro-urologie de langue française) et du comité de neuro-urologie de l’AFU (Associatio
Sep 24, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Benoit PeyronnetXavier Gamé
Jan 13, 2016·Neurourology and Urodynamics·Rhiannon K OwenDouglas G Tincello
Apr 22, 2017·Neurourology and Urodynamics·Florie BottetUNKNOWN Groupe d'Etude de Neuro-Urologie de Langue Française (GENULF) and the committee of NeuroUrology of the French Association of

❮ Previous
Next ❯

Citations

Jan 5, 2021·Current Opinion in Urology·Hatim ThakerMin Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.